Quantitative real-time polymerase chain reaction for evaluating DNAemia due to cytomegalovirus, Epstein-Barr virus, and BK virus in solid-organ transplant recipients

Clinical Infectious Diseases

Volumn 45, Issue 8, 2007, Pages 1056-1061

  Smith, Thomas F ^a   Espy, Mark J ^a   Mandrekar, Jayawant ^a   Jones, Mary F ^a   Cockerill, Franklin R ^a   Patel, Robin ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BK VIRUS; CLINICAL PRACTICE; CYTOMEGALOVIRUS; DNA EXTRACTION; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; GENE TARGETING; GRAFT RECIPIENT; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; BLOOD; CYTOMEGALIC INCLUSION BODY DISEASE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; STANDARD; VIREMIA; VIROLOGY; VIRUS INFECTION;

VIRUS DNA;

BK VIRUS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VIREMIA;

EID: 34848901357     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/521909     Document Type: Review

References (38)

1. Hoppe L, Marroni CA, Bressane R, et al. Impact of cytomegalovirus infection on long-term survival after orthotopic liver transplantation. Transplant Proc 2006; 38:1924-5.
2. Timuragaoglu A, Ugur-Bilgin A, Colak D, et al. Posttransplant lymphoproliferative disorders in transplant recipients. Transplant Proc 2006; 38:641-5.
3. Smith JM, McDonald RA, Finn LS, Healey PJ, Davis CL, Limaye AP. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant 2004; 4:2109-17.
4. Schirm J, Timmerije W, van der Bij W, et al. Rapid detection of infectious cytomegalovirus in blood with the aid of monoclonal antibodies. J Med Virol 1987; 23:31-40.
5. Mengoli C, Cusinato R, Biasolo MA, Cesaro S, Parolin C, Palu G. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection. J Med Virol 2004; 74:78-84.
6. Hernando S, Folgueira L, Lumbreras C, et al. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients. Transplant Proc 2005; 37:4094-6.
7. Allice T, Enrietto M, Pittaluga F, et al. Quantitation of cytomegalovirus DNA by real-time polymerase chain reaction in peripheral blood specimens of patients with solid organ transplants: comparison with end-point PCR and pp65 antigen test. J Med Virol 2006; 78:915-22.
8. Gaeta A, Nazzari C, Verzaro S, Latte MC, Fabri G, Mancini C. Application of real time PCR in post transplant monitoring of cytomegalovirus infection: comparison with other diagnostic approaches. New Microbiol 2006; 29:185-92.
9. Leruez-Ville M, Ouachee M, Delarue R, et al. Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma. J Clin Microbiol 2003; 41:2040-6.
10. Onishi Y, Mori S, Higuchi A, et al. Early detection of plasma cytomegalovirus DNA by real-time PCR after allogeneic hematopoietic stem cell transplantation. Tohoku J Exp Med 2006; 210:125-35.
11. Espy MJ, Uhl JR, Sloan LM, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 2006; 19:165-256.
12. Espy MJ, Uhl JR, Mitchell PS, et al. Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol 2000; 38:795-9.
13. Espy MJ, Rys PN, Wold AD, et al. Detection of herpes simplex virus DNA in genital and dermal specimens by LightCycler PCR after extraction using the IsoQuick, MagNA Pure, and BioRobot 9604 methods. J Clin Microbiol 2001; 39:2233-6.
14. Espy MJ, Ross TK, Teo R, et al. Evaluation of LightCycler PCR for implementation of laboratory diagnosis of herpes simplex virus infections. J Clin Microbiol 2000; 38:3116-8.
15. Wolk D, Mitchell S, Patel R. Principles of molecular microbiology testing methods. Infect Dis Clin North Am 2001; 15:1157-204.
16. Li H, Dummer JS, Estes WR, Meng S, Wright PF, Tang YW. Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol 2003; 41:187-91.
17. Cortez KJ, Fischer SH, Fahle GA, et al. Clinical trial of quantitative real-time polymerase chain reaction for detection of cytomegalovirus in peripheral blood of allogeneic hematopoietic stem-cell transplant recipients. J Infect Dis 2003; 188:967-72.
18. Mendez JC, Espy MJ, Smith TF, Wilson JA, Paya CV. Evaluation of PCR primers for early diagnosis of cytomegalovirus infection following liver transplantation. J Clin Microbiol 1998; 36:526-30.
19. Jayarama V, Marcello J, Ohagen A, et al. Development of models and detection methods for different forms of cytomegalovirus for the evaluation of viral inactivation agents. Transfusion 2006; 46:1580-8.
20. Machida U, Kami M, Fukui T, et al. Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation. J Clin Microbiol 2000; 38:2536-42.
21. Mengelle C, Sandres-Saune K, Pasquier C, et al. Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay. J Clin Microbiol 2003; 41:3840-5.
22. Garrigue I, Boucher S, Couzi L, et al. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients. J Clin Virol 2006; 36:72-5.
23. Bai X, Rogers BB, Harkins PC, et al. Predictive value of quantitative PCR-based viral burden analysis for eight human herpesviruses in pediatric solid organ transplant patients. J Mol Diagn 2000; 2:191-201.
24. Sokal RR, Rohlf FJ. Biometry: the principles and practice of statistics in biological research. 3rd ed. New York: WH Freeman, 1995.
25. Griscelli F, Barrois M, Chauvin S, Lastere S, Bellet D, Bourhis JH. Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR. J Clin Microbiol 2001; 39:4362-9.
26. Weinstock DM, Ambrossi GG, Brennan C, Kiehn TE, Jakubowski A. Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development. Bone Marrow Transplant 2006; 37:539-46.
27. Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 2005; 56:155-67.
28. Lim WH, Russ GR, Coates PT. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Nephrology (Carlton) 2006; 11:355-66.
29. Raj R, Frost AE. Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients. J Heart Lung Transplant 2005; 24:671-9.
30. Shitrit D, Shitrit AB, Dickman R, Sahar G, Saute M, Kramer MR. Gastrointestinal involvement of posttransplant lymphoproliferative disorder in lung transplant recipients: report of a case. Dis Colon Rectum 2005; 48:2144-7.
31. Paya CV, Fung JJ, Nalesnik MA, et al. Epstein-Barr virus-induced post-transplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation 1999; 68:1517-25.
32. Lucioni M, Capello D, Riboni R, et al. B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution. Transplantation 2006; 82:1013-23.
33. Gulley ML, Fan H, Elmore SH. Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting. J Mol Diagn 2006; 8:589-97.
34. Stevens SJ, Pronk I, Middeldorp JM. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen. J Clin Microbiol 2001; 39:1211-6.
35. Blanckaert K, De Vriese AS. Current recommendations for diagnosis and management of polyoma BK virus nephropathy in renal transplant recipients. Nephrol Dial Transplant 2006; 21:3364-7.
36. Si-Mohamed A, Goff JL, Desire N, Maylin S, Glotz D, Belec L. Detection and quantitation of BK virus DNA by real-time polymerase chain reaction in the LT-ag gene in adult renal transplant recipients. J Virol Methods 2006; 131:21-7.
37. Herman J, Van Ranst M, Snoeck R, Beuselinck K, Lerut E, Van Damme-Lombaerts R. Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique. Pediatr Transplant 2004; 8:485-92.
38. Viscount HB, Eid AJ, Griffin MD, Smith TF, Razonable R. Polyomavirus PCR as a surrogate marker of polyomavirus associated nephropathy. Transplantation 2007; 84:340-5.